| Identification | Back Directory | [Name]
(±)-N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine | [CAS]
599-54-2 | [Synonyms]
DL-Pantothenic acid
Pantothenic acid, DL- (8CI)
β-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-
(±)-N-(2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl)-β-alanine
rac-N-[(S*)-2,4-Dihydroxy-3,3-dimethylbutyryl]-β-alanine
(±)-N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine
3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid
3-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]propanoic acid
3-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]propionic acid
β-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (+-)- | [EINECS(EC#)]
209-965-4 | [Molecular Formula]
C9H17NO5 | [MOL File]
599-54-2.mol | [Molecular Weight]
219.24 |
| Hazard Information | Back Directory | [Uses]
Vitamin (enzyme cofactor). | [Definition]
ChEBI: A member of the class of pantothenic acids that is an amide formed from pantoic acid and beta-alanine. | [in vivo]
(±)-Pantothenic acid (3 × 200 mg/kg; IP, single dosage) blocks VPA-induced decreases in c-Myb and Pim-1 protein expression; reduces the incidence of NTD to 6.8% in VPA-injected CD-1 mice, while incidence of the untreated group is 23.6%[1]. |
|
|